Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MBX Biosciences Inc. Comm...

    NASDAQ: MBX · Real-Time Price · USD
    10.38
    -0.34 (-3.17%)
    At close: Jun 13, 2025, 3:59 PM
    9.85
    -5.11%
    After-hours: Jun 13, 2025, 07:39 PM EDT

    MBX Biosciences Common Stock Statistics

    Share Statistics

    MBX Biosciences Common Stock has 33.42M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 33.42M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,521

    FTD / Avg. Volume

    n/a
    		 0.87%

    Short Selling Information

    The latest short interest is 4.75M, so 14.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.75M

    Short % of Shares Out

    n/a
    		 14.2%

    Short % of Float

    n/a
    		 28.55%

    Short Ratio (days to cover)

    n/a
    		 18.53

    Valuation Ratios

    The PE ratio is -9.94 and the forward PE ratio is -4.01. MBX Biosciences Common Stock's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -9.94

    Forward PE

    n/a
    		 -4.01

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 7.9

    PB Ratio

    n/a
    		 2.39

    P/FCF Ratio

    n/a
    		 -11.08

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for MBX Biosciences Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 24.19, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 24.19

    Quick Ratio

    n/a
    		 24.19

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,440,046.51

    Employee Count

    n/a
    		 43

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.71, so MBX Biosciences Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.71

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 10.22

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 40.32

    Average Volume (20 Days)

    n/a
    		 290,307

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -68.19M

    Net Income

    n/a
    		 -61.92M

    EBITDA

    n/a
    		 -67.95M

    EBIT

    n/a
    		 -68.19M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 49.35M in cash and 171K in debt, giving a net cash position of 49.18M.

    Cash & Cash Equivalents

    n/a
    		 49.35M

    Total Debt

    n/a
    		 171K

    Net Cash

    n/a
    		 49.18M

    Retained Earnings

    n/a
    		 -137.5M

    Total Assets

    n/a
    		 245.93M

    Working Capital

    n/a
    		 233.79M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -54.68M and capital expenditures -874K, giving a free cash flow of -55.55M.

    Operating Cash Flow

    n/a
    		 -54.68M

    Capital Expenditures

    n/a
    		 -874K

    Free Cash Flow

    n/a
    		 -55.55M

    FCF Per Share

    n/a
    		 -1.66
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MBX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MBX is $38, which is 266.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $38

    Price Target Difference

    n/a
    		 266.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 23.31

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist